HK1257178A1 - 作為異檸檬酸脫氫酶抑制劑的化合物及其應用 - Google Patents
作為異檸檬酸脫氫酶抑制劑的化合物及其應用Info
- Publication number
- HK1257178A1 HK1257178A1 HK18116073.6A HK18116073A HK1257178A1 HK 1257178 A1 HK1257178 A1 HK 1257178A1 HK 18116073 A HK18116073 A HK 18116073A HK 1257178 A1 HK1257178 A1 HK 1257178A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- application
- chemical compound
- isocitrate dehydrogenase
- dehydrogenase inhibitor
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610580910 | 2016-07-21 | ||
| PCT/CN2017/093597 WO2018014852A1 (zh) | 2016-07-21 | 2017-07-20 | 作为异柠檬酸脱氢酶抑制剂的化合物及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1257178A1 true HK1257178A1 (zh) | 2019-10-18 |
Family
ID=60991952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18116073.6A HK1257178A1 (zh) | 2016-07-21 | 2018-12-14 | 作為異檸檬酸脫氫酶抑制劑的化合物及其應用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10961222B2 (zh) |
| EP (1) | EP3489230B1 (zh) |
| JP (1) | JP6772360B2 (zh) |
| KR (1) | KR102232614B1 (zh) |
| CN (2) | CN107641114B (zh) |
| CA (1) | CA3029343C (zh) |
| HK (1) | HK1257178A1 (zh) |
| TW (1) | TWI757312B (zh) |
| WO (1) | WO2018014852A1 (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018133856A1 (zh) * | 2017-01-22 | 2018-07-26 | 正大天晴药业集团股份有限公司 | 1，3，5-三嗪衍生物的盐及其晶体、它们的制备方法、药物组合物和用途 |
| CN110054614B (zh) * | 2018-01-19 | 2021-12-28 | 南京圣和药业股份有限公司 | 三嗪类idh抑制剂的可药用盐及其制备方法 |
| CN110051673B (zh) * | 2018-01-19 | 2022-03-11 | 南京圣和药业股份有限公司 | 一种包含三嗪类idh抑制剂的药物组合物及其用途 |
| KR102584855B1 (ko) * | 2018-06-26 | 2023-10-05 | 케이피씨 파마슈티컬스 인코포레이티드 | 벤즈이미다졸 유도체 및 idh1 억제제로서의 이의 용도 |
| WO2020048449A1 (zh) * | 2018-09-03 | 2020-03-12 | 正大天晴药业集团股份有限公司 | 包含1,3,5-三嗪衍生物或其盐的固体药物组合物 |
| CN110208449B (zh) * | 2019-05-24 | 2021-07-02 | 湖南华腾制药有限公司 | 三嗪化合物的分析检测方法 |
| CN114502537A (zh) * | 2019-09-29 | 2022-05-13 | 贝达药业股份有限公司 | 突变型idh2抑制剂及其应用 |
| CN113350347B (zh) * | 2020-03-05 | 2023-07-04 | 安徽中科拓苒药物科学研究有限公司 | 吲唑类化合物的用途 |
| AU2021284433A1 (en) | 2020-06-01 | 2022-12-01 | Otsuka Pharmaceutical Factory, Inc. | Adhesion-preventing agent and method for preventing adhesion using same |
| US11865079B2 (en) | 2021-02-12 | 2024-01-09 | Servier Pharmaceuticals Llc | Therapeutically active compounds and their methods of use |
| KR20230145402A (ko) * | 2021-02-12 | 2023-10-17 | 르 라보레또레 쎄르비에르 | 치료적 활성 화합물 및 이의 사용 방법 |
| MX2023013664A (es) * | 2021-06-15 | 2024-01-08 | Wigen Biomedicine Tech Shanghai Co Ltd | Inhibidor de mutante de idh y uso del mismo. |
| CN118355008A (zh) * | 2022-01-11 | 2024-07-16 | 正大天晴药业集团股份有限公司 | 一种1,3,5-三嗪衍生物的制备方法 |
| CN115536637A (zh) * | 2022-10-24 | 2022-12-30 | 陕西中医药大学 | 一种均三嗪类衍生物及其合成方法与用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2800743T1 (en) * | 2012-01-06 | 2018-08-31 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and methods for their use |
| MY185687A (en) * | 2013-07-11 | 2021-05-30 | Agios Pharmaceuticals Inc | N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer |
| CN105473560B (zh) * | 2013-07-11 | 2020-01-17 | 安吉奥斯医药品有限公司 | 治疗活性化合物及其使用方法 |
| WO2015003360A2 (en) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| KR20160077688A (ko) * | 2014-12-24 | 2016-07-04 | 장대규 | 휴대 전자기기용 살균기 |
| WO2016177347A1 (en) | 2015-05-07 | 2016-11-10 | Teligene Ltd | Heterocyclic compounds as idh2 inhibitors |
| JP6786086B2 (ja) | 2015-07-30 | 2020-11-18 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd. | １，３，５−トリアジン誘導体及びその使用方法 |
-
2017
- 2017-07-20 EP EP17830486.1A patent/EP3489230B1/en active Active
- 2017-07-20 CA CA3029343A patent/CA3029343C/en active Active
- 2017-07-20 JP JP2019500677A patent/JP6772360B2/ja active Active
- 2017-07-20 KR KR1020197000830A patent/KR102232614B1/ko active IP Right Grant
- 2017-07-20 CN CN201710595235.3A patent/CN107641114B/zh active Active
- 2017-07-20 US US16/312,666 patent/US10961222B2/en active Active
- 2017-07-20 TW TW106124407A patent/TWI757312B/zh active
- 2017-07-20 CN CN201780029958.5A patent/CN109890806B/zh active Active
- 2017-07-20 WO PCT/CN2017/093597 patent/WO2018014852A1/zh unknown
-
2018
- 2018-12-14 HK HK18116073.6A patent/HK1257178A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201803867A (zh) | 2018-02-01 |
| US10961222B2 (en) | 2021-03-30 |
| TWI757312B (zh) | 2022-03-11 |
| CN109890806A (zh) | 2019-06-14 |
| KR102232614B1 (ko) | 2021-03-29 |
| EP3489230B1 (en) | 2021-12-08 |
| CN109890806B (zh) | 2022-04-26 |
| CA3029343A1 (en) | 2018-01-25 |
| US20190161473A1 (en) | 2019-05-30 |
| KR20190015564A (ko) | 2019-02-13 |
| WO2018014852A1 (zh) | 2018-01-25 |
| JP6772360B2 (ja) | 2020-10-21 |
| JP2019520410A (ja) | 2019-07-18 |
| EP3489230A4 (en) | 2020-01-08 |
| CN107641114A (zh) | 2018-01-30 |
| EP3489230A1 (en) | 2019-05-29 |
| CA3029343C (en) | 2021-02-09 |
| CN107641114B (zh) | 2022-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1257178A1 (zh) | 作為異檸檬酸脫氫酶抑制劑的化合物及其應用 | |
| EP3541932A4 (en) | CRISPR-CAS9 INHIBITORS | |
| IL261167A (en) | Heteroaryl pad4 inhibitors | |
| ZA201801056B (en) | Heteroaryl compounds as irak inhibitors and uses thereof | |
| ZA201800975B (en) | Heteroaryl compounds as irak inhibitors and uses thereof | |
| EP3344039A4 (en) | SMALL DYRK1A INHIBITORY MOLECULES AND USES THEREOF | |
| EP3331530A4 (en) | Mthfd2 inhibitors and uses thereof | |
| HK1252449A1 (zh) | 突變的異檸檬酸脫氫酶idh1 r132h的抑制劑 | |
| GB201514756D0 (en) | Compound and method of use | |
| EP3373969A4 (en) | GLYCANINTERAGING COMPOUNDS AND METHOD OF USE | |
| HK1248684A1 (zh) | Usp7抑制劑化合物及使用方法 | |
| IL259796A (en) | Aza-benzimidazole inhibitors of pad4 | |
| HK1247607A1 (zh) | P62-zz化學抑制劑 | |
| EP3405477C0 (en) | INHIBITORS OF TRANSGLUTAMINASE | |
| ZA201704116B (en) | 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase | |
| EP3884939C0 (en) | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | |
| EP3426244C0 (en) | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND THEIR USES | |
| SG10202006699XA (en) | Inhibition of allergic reaction using an il-33 inhibitor | |
| EP3177327A4 (en) | Inhibitors of myh7b and uses thereof | |
| EP3282846A4 (en) | Inhibitors of the notch transcriptional activation complex and methods for use of the same | |
| IL247921A0 (en) | Glutaminase inhibitor compounds, preparations containing them and their uses | |
| EP3347003A4 (en) | THREATENER BINDINGS AND METHOD FOR USE THEREOF | |
| HUE057149T2 (hu) | Mikromolekula vegyület, eljárás szintézisére és alkalmazására | |
| EP3484888A4 (en) | SOLID FORMS OF A TTK INHIBITOR | |
| EP3285583A4 (en) | Low Molecular MCL-1 inhibitors and uses thereof |